New Zealand King Salmon Investments Limited logo

NZK 1HY24 Half Year Results

Half Year Results20 September 2023NZKConsumer Staples

Market Announcement
21 September 2023

NZK - NEW ZEALAND KING SALMON INVESTMENTS LIMITED ANNOUNCES 1HY24 RESULT


POSITIVE PROGRESS

New Zealand King Salmon Investments Ltd (NZX & ASX: NZK) reports its financial performance for

the six-month period ended 31 July 2023 (1HY24). Key points include:


• 1HY24 net profit for the year of $10.6 million, compared to a net loss of $24.5

million in 1HY23.

• 1HY24 pro-forma EBITDA of $10.7 million, compared to an EBITDA loss of $12.7

1

million

in 1HY23.

• Sales volumes increased from 2,885MT in 1HY23 to 3,024MT in 1HY24 (an increase

of 5%).

• Revenues increased from $80.0 million in 1HY23 to $91.6 million in 1HY24 (an increase

of 14%).

• The mortality cost decreased from $22.3 million in 1HY23 to $7.8m in 1HY24.

• Earnings guidance range of pro-forma EBITDA has been revised up to $23.5m -

$27.5m (Original guidance range of $21m - $25m provided to market in March

2023).

1

1HY23 numbers restated as NZKS is no longer reversing the impacts of NZ IFRS 16 leases as

previously communicated.



New Zealand King Salmon Chairman Mark Dewdney noted : “The first half result has seen a

continuation of our turnaround which started in FY23. Our new farming strategies have resulted in

reductions in mortality, with mortality reducing from $22.3m to $7.8m, when compared to the prior

comparable period. This, combined with a focus on operational excellence across our processing and

sales operations has resulted in a strong result for the first half of FY24.


I would like to recognise the leadership of Graeme Tregidga who as acting Chief Executive led the

company extremely well through a challenging set of circumstances. The Board wanted to

acknowledge the way Graeme navigated NZKS through a period of immense change and delivered a

strong set of results. We are pleased to be retaining Graeme’s talents and corporate knowledge in

the business as he returns to the GM of Sales role.


It is an exciting time for the company; with performance improving, the appointment of a new Chief

Executive Officer, Carl Carrington, and the successful completion of the Blue Endeavour resource

consent application mediation. Carl has joined at an exciting time and the Board is looking forward to

working with Carl and the whole NZKS team to continue to strengthen the resilience of and optimise the

existing business, while continuing to develop growth options as part of a strategic and operational reset”.


Carl said: “As a business real progress has been made in the past 12 months. We have a truly world-

class product and there remains a lot of opportunity within both the existing business and future

growth options. Reflecting on his first couple of months in the role Carl noted “I want to thank our

many stakeholders who support what we do, i t’s a pleasing set of results and we acknowledge we

have more work to do”.


The Board is providing a revised pro-forma EBITDA guidance in a range of $23.5m - $27.5m from $21m -

$25m for FY24.

Authorised by:
Board of Directors of New Zealand King Salmon Investments Limited



For investor or analyst queries, please contact:

Carl Carrington, CEO, New Zealand King Salmon Investments Ltd,

carl.carrington@kingsalmon.co.nz

Ben Rodgers, CFO and Company Secretary, New Zealand King Salmon Investments Ltd,

ben.rodgers@kingsalmon.co.nz



About New Zealand King Salmon

New Zealand King Salmon is the world’s largest aquaculture producer of the premium King salmon

species. We operate under our four key brands: Ōra King, Regal, Southern Ocean, and Omega Plus,

as well as our New Zealand King Salmon label. We have been growing and selling King salmon to

consumers for more than 30 years.


More information can be found at www.kingsalmon.co.nz

---

NZK
Results announcement

31 July 2023



Results for announcement to the market

Name of issuer New Zealand King Salmon Investments Limited

Reporting Period 6 months to 31 July 2023

Previous Reporting Period 6 months to 31 July 2022

Currency NZD

Amount (000s) Percentage change

Revenue from continuing

operations

$91,561 14%

Total Revenue $91,561 14%

Net profit/(loss) from

continuing operations

$10,630 <>%

Total net profit/(loss) $10,630 <>%

Interim Dividend

Amount per Quoted Equity

Security

Nil - Dividends remain on hold as NZK develops production

growth options

Imputed amount per Quoted

Equity Security

N/A

Record Date N/A

Dividend Payment Date N/A

Current period Prior comparable period

Net tangible assets per

Quoted Equity Security

$0.32 $0.25

A brief explanation of any of

the figures above necessary

to enable the figures to be

understood

Increase net tangible assets reflects the recovery of the

business (including biological asset values) following the

mortality event which impacted FY22 and FY23 results.

Authority for this announcement

Name of person


authorised

to make this announcement

Ben Rodgers

Contact person for this

announcement

Ben Rodgers

Contact phone number 03 548 5714

Contact email address Ben.rodgers@kingsalmon.co.nz

Date of release through MAP


21/09/2023


Unaudited financial statements accompany this announcement.

---

NEW ZEALAND KING SALMON INVESTMENTS LIMITED AND
SUBSIDIARIES

INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED 31 JULY 2023

1HY24

CONTENTS
FOR THE SIX MONTHS ENDED 31 JULY 2023

Page

Corporate directory3

Interim consolidated statement of comprehensive income 4

Interim consolidated statement of financial position5

Interim consolidated statement of changes in equity6

Interim consolidated statement of cash flows7

Notes to the interim consolidated financial statements

8

2

NEW ZEALAND KING SALMON INVESTMENTS LIMITED AND SUBSIDIARIES
CORPORATE DIRECTORY

BOARD OF DIRECTORSBANKERSNEW ZEALAND KING SALMON

John William Dudley Ryder The Bank of New ZealandINVESTMENTS LIMITED

Independent Non-Executive ChairmanDeloitte CentreTicker: NZK

(Resigned 14 June 2023)Level 6, 80 Queen StreetListed on the NZX Main Board and

Mark DewdneyAucklandas a Foreign Exempt Listing on the

Independent Non-Executive ChairmanNew ZealandASX

(Appointed 14 June 2023)NZ Company number: 2161790

Jack Lee PorusKiwibank

Non-Executive DirectorLevel 9, 20 Customhouse QuayRegistered Office

Paul James SteereWellington17 Bullen Street

Independent Non-Executive DirectorNew ZealandTahunanui

Chiong Yong TiongNelson 7011

Non-Executive DirectorAUDITORNew Zealand

Catriona MacleodErnst & Young (EY)

Independent Non-Executive DirectorLevel 4, 93 Cambridge TerracePostal Address

Carol ChenChristchurch PO Box 1180 Nelson 7040

Non-Executive DirectorNew ZealandNew Zealand

Victoria Taylor

Independent Non-Executive DirectorLAWYERSTelephone

Chapman Tripp+64 3 548 5714

Audit and Finance CommitteeLevel 34, 15 Customs Street West

Paul Steere (Chair)AucklandWebsite

Jack Porus New Zealand

www.kingsalmon.co.nz

Mark Dewdney (Appointed 14 June 2023)

John Ryder (resigned 14th June 2023)

Gascoigne WicksInvestor Relations

79 High Streetinvestor@kingsalmon.co.nz

Nominations and Remuneration CommitteeBlenheim

Victoria Taylor (Chair)New ZealandSHARE REGISTRY

Jack PorusComputershare Investor

Mark Dewdney (Appointed 14 June 2023)

Duncan CotterillServices Limited

197 Bridge StreetLevel 2, 159 Hurstmere Road

Health, Safety and Risk CommitteeNelsonTakapuna

Catriona Macleod (Chair)New ZealandAuckland 0622

Chiong Yong TiongNew Zealand

Mark Dewdney (Appointed 14 June 2023)

+64 9 488 8777

enquiry@computershare.co.nz

Fish Farming Review Committee

Jack Porus (Chair)Computershare Investor

Catriona MacleodServices Pty Limited

Mark Dewdney (Appointed 14 June 2023)

Yarra Fall

452 Johnston Street

Abbotsford VIC 3001

Australia

+61 3 9415 4083

enquiry@computershare.co.nz

3

INTERIM CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
FOR THE SIX MONTHS ENDED 31 JULY 2023

UNAUDITEDUNAUDITED

31 July 202331 July 2022

Note$000$000

Revenue from contracts with customers1491,561 80,033

Cost of goods sold including fair value uplift at point of harvest6(84,435) (89,921)

Fair value gain on biological transformation731,189 13,222

Freight costs to market(11,205) (11,379)

Gross profit

27,110 (8,046)

Other income3,974 3,312

Sales, marketing and advertising expenses(5,229) (6,324)

Distribution overheads(1,675) (1,818)

Corporate expenses(5,721) (5,109)

Other expenses-

Earnings before interest, tax, depreciation and amortisation

18,459 (17,985)

Depreciation and amortisation expense(3,852) (4,359)

Finance income457 116

Finance expenses(183) (1,276)

Profit / (Loss) before tax

14,881 (23,504)

Income tax credit / (expense)

(4,251) (984)

Profit / (Loss) after tax

10,630 (24,487)

Other comprehensive income

Exchange differences on translation of foreign operations175 674

Movement on cash flow hedges(2,687) (1,543)

Release of early closed out foreign exchange contracts

(3,551) (3,044)

Deferred tax on early closed out foreign exchange contracts

994 852

Income tax effect of movement on cash flow hedges

747 154

Net other comprehensive income/ (loss)(4,322) (2,907)

Total comprehensive income / (loss)

6,308 (27,394)

UNAUDITEDUNAUDITED

Earnings per share31 July 202331 July 2022

Basic earnings per share

4

0.02$ (0.05)$

Diluted earnings per share

4

0.02$ (0.05)$

The above interim consolidated statement of comprehensive income should be read in conjunction with the accompanying notes.

Other comprehensive income that may be reclassified to profit or loss in subsequent periods:

4

INTERIM CONSOLIDATED STATEMENT OF FINANCIAL POSITION
AS AT 31 JULY 2023

UNAUDITEDAUDITED

31 July 202331 January 2023

ASSETSNote$000$000

Current assets

Cash and cash equivalents28,66619,221

Trade and other receivables514,74016,573

Taxation receivable- 164

Inventories626,81729,729

Biological assets770,20660,348

Derivative financial assets101,4231,906

Total current assets

141,852127,941

Non-current assets

Property, plant and equipment46,94948,176

Biological assets710,30412,344

Derivative financial assets102,5554,106

Intangible assets3,3983,486

Right-of-use assets3,9074,316

Deferred tax asset- 919

Total non-current assets

67,11373,347

TOTAL ASSETS

208,965201,288

LIABILITIES

Current liabilities

Trade and other payables913,46813,662

Employee benefits3,3623,465

Borrowings8750750

Lease liabilities1,0071,191

Other financial liabilities13269278

Derivative financial liabilities104,0183,112

Taxation payable998-

Total current liabilities

23,87222,458

Non-current liabilities

Employee benefits480501

Borrowings82,7502,750

Lease liabilities3,1093,328

Deferred tax liabilities449-

Derivative financial liabilities104,0734,345

Total non-current liabilities

10,86110,924

TOTAL LIABILITIES

34,73333,382

NET ASSETS

174,232167,906

EQUITY

Share capital12180,143180,143

Reserves3,1197,423

Retained earnings(9,030) (19,660)

TOTAL EQUITY

174,232167,906

DirectorDirector

20 September 202320 September 2023

The above interim consolidated statement of financial position should be read in conjunction with the accompanying notes.

For and on behalf of the Board, who authorised the issue of these financial statements on 20 September 2023

5

INTERIM CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE SIX MONTHS ENDED 31 JULY 2023

Share Capital

Foreign

Currency

Translation

Reserve

Hedge

Reserve

Share Based

Payment

Reserve

Retained

Earnings

Total Equity

UNAUDITED$000$000$000$000$000$000

Balance as at 1 February 2023

180,143(614) 7,209828(19,660) 167,906

Profit / (loss) for the period- -

-

- 10,630

10,630

Other comprehensive income/(loss)- 175(4,497) - -

(4,322)

Total comprehensive income/(loss) for the period

- 175(4,497) - 10,6306,308

Share based payment expense- - - 18-

18

Balance as at 31 July 2023

180,143(439) 2,712846(9,030) 174,232

UNAUDITED

Balance as at 1 February 2022

122,606(948) 10,0031,120(21,551) 111,230

Profit / (loss) for the period- - - (24,487)

(24,487)

Other comprehensive income/(loss)- 674(3,581) - - (2,907)

Total comprehensive income/(loss) for the period

- 674(3,581) - (24,487) (27,394)

Issue of Share Capital (net of costs)57,537- - - -

57,537

Share based payment expense- - - (153) -

(153)

Balance as at 31 July 2022

180,143(274) 6,422967(46,038) 141,220

The above interim consolidated statement of changes in equity should be read in conjunction with the accompanying notes.

6

INTERIM CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE SIX MONTHS ENDED 31 JULY 2023

UNAUDITEDUNAUDITED

31 July 202331 July 2022

$000$000

Operating activities

Receipts from customers92,282 85,959

Payments to suppliers(61,118) (54,578)

Payments to employees(19,849) (20,809)

Interest received457 116

Interest paid(126) (1,037)

Insurance and settlement income- 2

Government grants received99 162

Income tax paid/(received)23 (533)

Net cash flows (used in) / from operating activities

11,768 9,282

Investing activities

Proceeds from sale of property, plant and equipment17 13

Purchase of property, plant and equipment(1,573) (4,560)

Purchase of intangible assets(129) (20)

Net cash flow (used in) / from investing activities

(1,685) (4,567)

Financing activities

Proceeds from borrowings- 51,500

Repayment of borrowings- (96,023)

Gross proceeds from share issue- 57,536

Payment of lease liabilities(726) (877)

Net cash flows (used in) / from financing activities

(726) 12,136

Net increase / (decrease) in cash and cash equivalents

9,357 16,851

Net foreign exchange difference

88 36

Cash and cash equivalents at 1 February

19,221 2,913

Cash and cash equivalents at 31 July

28,666 19,800

The above interim consolidated statement of cash flows should be read in conjunction with the accompanying notes.

7

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 JULY 2023

1.CORPORATE INFORMATION

2.BASIS OF PREPARATION

3.

NEW STANDARDS,INTERPRETATIONS, AND AMENDMENTS ADOPTED BY THE GROUP

The Group's business is seasonal with higher sales in the summer months and higher mortality rates are typically highest in

the January to April period due to higher water temperatures at that time. This impacts on month to month profitability.

The condensed interim consolidated financial statements of New Zealand King Salmon Investments Limited (the Company)

and its subsidiaries (together the Group) for the six months ended 31 July 2023 were authorised for issue by the Directors on

20 September 2023.

New Zealand King Salmon Investments Limited is a profit-orientated company incorporated and domiciled in New Zealand.

The Company is registered under the Companies Act 1993 and listed on the NZX Main Board ("NZX") and the Australian

Securities Exchange ("ASX"). The Company is an FMC reporting entity under the Financial Markets Conduct Act 2013. The

Group is principally engaged in the farming, processing and sale of premium salmon products.

The interim condensed consolidated financial statements do not include all the information and disclosures required in the

annual financial statements, and should be read in conjunction with the Group's annual consolidated financial statements as at

31 January 2023.

The accounting policies adopted in the interim condensed financial statements are consistent with those applied in the annual

financial statements as at 31 January 2023. Management have applied the same principles and used the same key sources of

estimation in the preparation of the interim financial statements as those applied in the consolidated financial statements for

the period ended 31 January 2023. The Group has not early adopted any standard, interpretation or amendment that has been

issued but is not yet effective.

The condensed interim consolidated financial statements have been prepared in accordance with Generally Accepted

Accounting Practice in New Zealand (NZ GAAP) as appropriate for interim financial statements. They have been prepared in

accordance with NZ IAS 34 Interim Financial Reporting. The interim financial statements and the comparative information for

the six months ended 31 July 2022 are unaudited. The comparative information for the year ended 31 January 2023 are

audited.

8

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 JULY 2023

4.EARNINGS PER SHARE

UNAUDITEDUNAUDITED

31 July 202331 July 2022

Earnings per share

$000$000

Profit / (loss) attributable to ordinary equity holders 10,630(24,487)

# of Shares# of Shares

000000

Weighted average number of ordinary shares for diluted earnings per share541,455541,455

Basic earnings per share

0.02$ (0.05)$

Diluted earnings per share

0.02$ (0.05)$

5.TRADE AND OTHER RECEIVABLESUNAUDITEDAUDITED

31 July 202331 January 2023

Trade and other receivables$000$000

Trade receivables13,51213,492

Allowance for expected credit losses(446) (63)

Prepayments1,2012,518

Other receivables473626

Total trade and other receivables14,74016,573

6.INVENTORIES

UNAUDITEDAUDITED

31 July 202331 January 2023

Inventories

$000$000

Raw materials7,0706,419

Work in progress1,9661,554

Finished goods17,78121,756

Total inventories26,81729,729

UNAUDITEDUNAUDITED

31 July 202331 July 2022

Amount of inventories recognised as an expense in the statement of comprehensive income

$000$000

Cost of inventories recognised as an expense86,148 91,243

Movement in net realisable value provision(1,713) (1,322)

Total cost of goods sold including fair value uplift at point of harvest84,435 89,921

7.

BIOLOGICAL ASSETS

UNAUDITED

Cost Fair valueTotal

Biological assets

$000$000$000

As at 1 February 2023

42,88129,81172,692

Increase due to biological transformation

1

41,86928,71970,588

Decrease due to harvest

2

(30,874) (26,561) (57,435)

Decrease due to mortality

3

(7,806) - (7,806)

Changes in fair value

4

- 2,4712,471

As at 31 July 2023

46,07034,44080,510

UNAUDITED

Cost Fair valueTotal

Biological assets

$000$000$000

As at 1 February 2022

50,57524,38674,961

Increase due to biological transformation

1

35,47611,72547,201

Decrease due to harvest

2

(25,833) (20,385) (46,218)

Decrease due to mortality

3

(22,258) - (22,258)

Changes in fair value

4

- 1,4981,498

As at 31 July 2022

37,96017,22455,184

Basic earnings per share amounts are calculated by dividing the profit for the year attributable to shareholders of the Company by the weighted average

number of ordinary shares on issue during the year. Diluted earnings per share assumes conversion of all potential ordinary shares in determining the

weighted average number of ordinary shares on issue.

The cost of inventories recognised as an expense for the period ended 31 July 2023 includes a fair value uplift at point of harvest of $27,510k (31 July

2022: $23,240k).This cost is included in cost of goods sold in the Statement of Comprehensive Income.

The cost of inventory includes fish harvested at the fair value less cost to sell at harvest date, based on management’s expected future sales pricing and

mix of product (“deemed cost”). As at 31 July 2023 no volumes were forecasted to be sold at returns materially below deemed cost plus further

manufacturing costs. As a result, the overall deemed cost of inventory on hand takes this into account and therefore increases the carrying value by the

impact of the higher expected sales prices.

The Group has two hatcheries (31 July 2022: three hatcheries) in the South Island and six operational (31 July 2022: nine operational) marine salmon

farms in the Marlborough Sounds. The fish livestock typically grow for up to 31 months before harvest.

9

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 JULY 2023

BIOLOGICAL ASSETS (CONTINUED)

AUDITED

Cost Fair valueTotal

Biological assets

$000$000

$000

As at 1 February 2022

50,57524,38674,961

Increase due to biological transformation

1

77,71242,967

120,679

Decrease due to harvest

2

(59,463) (44,203)

(103,666)

Decrease due to mortality

3

(25,943) - (25,943)

Changes in fair value

4

- 6,661 6,661

As at 31 January 2023

42,881 29,811 72,692

1

2

3

4

UNAUDITEDUNAUDITED

31 July 202331 July 2022

Fair value gain / (loss) recognised in profit and loss

$000$000

Gain arising from growth of biological assets28,71911,724

Movement in fair value of biological assets2,4701,498

Total fair value gain on biological transformation31,189 13,222

UNAUDITEDAUDITED

31 July 202331 January 2023

Biological Assets

$000$000

Current70,20660,348

Non-current10,30412,344

Total Biological Assets80,51072,692

UNAUDITEDUNAUDITED

31 July 202331 July 2022

Harvested biomass

tonnestonnes

Total live weight harvested for the period 3,401 3,152

UNAUDITEDAUDITED

31 July 202331 January 2023

Estimated closing biomass

tonnestonnes

Closing fresh water stocks111163

Closing seawater stocks4,6594,457

Total estimated closing biomass live weight 4,7704,620

Fair value measurement

Fair value risk and sensitivity

The estimated unrealised fair value gain from cost at 31 July 2023 has increased due to a decrease in forecasted mortalities and a consequential increase

in the forecasted harvest. Mortality assumptions made in the fair value model are in line with the FY24 forecast which sees the lower motalities

experienced at the end of FY23 continue into FY24. Average price increases are forecast due to continuing robust global demand for the product and rising

costs of inputs. Changes in these assumptions will impact the fair value calculation. The realised profit which is achieved on the sale of inventory will

differ from the calculations of fair value of biological assets because of changes in key factors such as the final market destinations and product mix of

inventory sold, changes in price, foreign exchange rates, harvest weight, growth rates, mortality, cost levels and differences in harvested fish quality.

Leaving all other variables constant a 15% increase/decrease in average future sales prices would increase/decrease the fair value of biological assets on

hand and profit before tax by $16.6m (31 January 2023: $14.6m) (excludes the impact of finished goods), while a 15% increase/decrease in future harvest

volume would increase/decrease the fair value of biological assets on hand and profit before tax by $ 5.2m (31 January 2023: $2.2m).

Measurement of fair value is performed using a fair value model. The method of valuation therefore falls into level three of the fair value hierarchy as the

inputs are unobservable inputs.

A 15% increase/decrease in costs to sell would decrease/increase the fair value of biological assets on hand and profit before tax by $11.3m (31 January

2023: $13.6m). Changes in fish health and environmental factors may affect the quality of harvested fish, which may be reflected in realised profit via both

achieved sales price and production costs.

The Group is exposed to financial risks relating to the production of salmon stock including increasing climate change volatility, climatic events, disease

and contamination of water space.

The valuation of biological assets is carried out separately for each site at a brood and strategy level. Estimated actual cost up to the date of harvest per

site is used to measure the expected margin at the time the fish is defined as ready for harvest, being 4.0kg live weight. Selling price is estimated at

balance date based on the most relevant future market price at expected harvest date. The expected gross margin is recognised proportionately based on

average biomass at reporting date. Fair value measurement commences at the date of transfer to sea water as this is considered the point at which the

fish commence their grow out cycle.

The Group seeks to produce and market the highest quality salmon products. Extensive monitoring and benchmarking is carried out to provide optimum

conditions and diets to maximise fish performance during the grow out cycle. Sales are maintained in a range of brands, products and markets to

maximise returns from the quality mix of fish harvested. The Group has insurance to cover some of the risks relating to the livestock.

Biological transformation fair value is impacted by volume increases and fish weight at reporting date relative to the target harvest weight of 4 kgs (proportional recognition).

Harvested fair value is included under cost of goods sold in the statement of comprehensive income and is calculated by multiplying the current period's harvest (biomass) by the prior years

expected gross margin per kg (recognised at 100%).

Changes in fair value are impacted by movements in margin primarily being changes in sales price and costs to sell (fish cost, harvest, processing and freight to market).

Mortality cost is expensed directly to the statement of comprehensive income within the cost of goods sold in the period which it occurs and is not subject to a fair value uplift.

10

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 JULY 2023

8.INTEREST BEARING LOANS AND BORROWINGS

UNAUDITEDAUDITED

31 July 202331 January 2023

Current interest bearing loans and borrowings

$000

$000

Secured bank loans

750750

Total current interest bearing loans and borrowings

750750

31 July 202331 January 2023

Non-current interest bearing loans and borrowings$000$000

Secured bank loans2,7502,750

Total current interest bearing loans and borrowings

2,7502,750

9.TRADE AND OTHER PAYABLES

UNAUDITEDAUDITED

31 July 202331 January 2023

$000$000

Trade payables11,99011,327

Other payables1,4782,335

Total trade and other payables

13,46813,662

10.FAIR VALUE OF FINANCIAL INSTRUMENTS

The following financial instruments of the Group are carried at fair value:

UNAUDITEDAUDITED

31 July 202331 January 2023

Current derivative financial assets$000$000

Forward exchange contracts9991,341

Foreign exchange options424565

Total Current derivative financial assets

1,4231,906

Non-current derivative financial assets

Forward exchange contracts802928

Foreign exchange options1,7533,178

Total Non-current derivative financial assets

2,5554,106

Current derivative financial liabilities

Forward exchange contracts2,1472,123

Foreign exchange options1,871989

Total Current derivative financial liabilities

4,0183,112

Non-current derivative financial liabilities

Forward exchange contracts872369

Foreign exchange options3,2013,976

Total Non-current derivative financial liabilities

4,0734,345

Valuation methods

Level 1: Quoted prices in active markets for identical assets or liabilities that the entity can access at the measurement date

Level 3: Inputs for the assets or liabilities that are not based on observable market data (unobservable inputs)

The carrying value of cash and short term deposits, trade receivables, trade payables and other current liabilities is considered a reasonable approximation

to their fair value due to the short term maturities of these instruments.

The Company has a facility with BNZ for $6.5m (expiry 30 April 2024), secured by a general security over the assets of the Group. Nothing was drawn as

at 31 July 2023 and the facility was cancelled at the request of New Zealand King Salmon in August 2023.

The company also secured a Business Finance Scheme Loan via BNZ for $5m (expiry October 2025) that arose from the Government providing financial

assistance following the pandemic virus Covid-19. At 31 July 2023 the balance drawn on the Business Finance Scheme was $3.5m.

Financial instruments have been categorised into the following hierarchy and valued according to the following definitions, based on the lowest level input

that is significant to the fair value measurement as a whole:

Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability either directly (i.e. as prices) or indirectly (i.e.

derived from prices)

All derivative financial instruments for which a fair value is recognised have been categorised within level 2 of the fair value hierarchy. Industry experts

have provided the fair values for all derivatives based on an industry standard model. There were no transfers between Level 1 and Level 2 during the

period ended 31 July 2023 (31 July 2022 - nil).

11

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 JULY 2023

11.COMMITMENTS AND CONTINGENCIES

UNAUDITED

Capital commitments

Contingencies

Guarantees

12.CAPITAL AND RESERVES

UNAUDITEDAUDITED

Share capital

31 July 202331 January 2023

Issued shares000000

Ordinary shares541,455 541,455

Total issued shares

541,455 541,455

UNAUDITEDAUDITEDUNAUDITEDAUDITED

31 July 202331 January 202331 July 202331 January 2023

Movement in ordinary share capital000000$000$000

The beginning of the period541,455 140,638 180,143122,606

Share issue- 400,817 - 57,537

Total Share capital as at period end

541,455 541,455180,143180,143

Reserves

Foreign currency translation reserve

Hedge reserve

UNAUDITEDAUDITED

31 July 202331 January 2023

$000$000

(1,940)

2,804

Total gain / (loss) on hedge reserves

(1,940) 2,804

Retained earnings

Share based payment reserve

Share Capital# of Shares

Retained earnings represents the profits retained in the business.

The foreign currency translation reserve is used to record exchange difference arising from the translation of the financial statements of the foreign

subsidiary.

The share based payment reserve relates to one long term incentive (LTI) scheme and two employee share ownership schemes. All of these schemes

involve the Company making interest-free limited recourse loans to selected personnel to acquire shares in the Company. The employees must remain in

employment for the duration of the vesting or escrow periods before the employees receive the full benefit of share ownership subsequent to repayment of

the loan balance remaining at time of vesting.

The hedge reserve represents the unrealised gains and losses on interest rate swaps and foreign currency forward contracts that the Group has taken out

in order to mitigate interest rate and foreign currency risks, net of deferred tax. Also included are the realised gains on early closed foreign currency forward

contracts where the hedged future cash flows are still expected to occur (net of tax).

Unrealised gain / (loss)

Ordinary shares are fully paid with no par value. Each ordinary share has an equal right to vote, to participate in dividends and to share in any surplus on

winding up of the Company. No dividend was declared nor paid during the 6 months to 31 July 2023 (6 months to 31 July 2022: No dividend was declared

or paid).

The Group has entered into agreements to purchase plant and equipment. As at 31 July 2023 the total commitment is $463k (31 July 2022: $945k).

The Group has a contingent liability at 31 July 2023 of $975k in respect of a fish transport contract requiring the Group to purchase four bulk tankers (one

tanker purchased late 2021), should the fish transport contract be terminated early (31 July 2022: $1,121k).

The group has three guarantee facilities at 31 July 2023 totalling $132k (31 July 2022: $132k).

12

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 JULY 2023

13.RELATED PARTY DISCLOSURES

Subsidiaries

New Zealand King Salmon Investments Limited has the following trading subsidiaries.

Subsidiary

Country of Incorporation

The New Zealand King Salmon Co. LimitedNew Zealand100%

New Zealand King Salmon Exports LimitedNew Zealand100%

The New Zealand King Salmon Pty LimitedAustralia100%

New Zealand King Salmon USA IncorporatedUnited States of America100%

Transactions with related parties


UNAUDITEDUNAUDITED

31 July 202331 July 2022

Related party payments$000$000

Goods and services purchased from other related parties- -

Directors fees241 205

Total related party payments

241 205

Related party sales$000$000

Goods sold to related parties

1

1,783-

Total related party sales

1,783-

UNAUDITEDAUDITED

Amounts owing to related parties

31 July 202331 January 2023

Current amounts owing to related parties$000$000

Other amounts owing to related parties233233

Fees payable to directors3645

Total current amounts owing to related parties

269278

1

14.DISAGGREGATION OF REVENUE

UNAUDITEDUNAUDITED

31 July 202331 July 2022

Revenue by Product Group$000$000

Whole Fish46,44336,908

Fillets, Steaks & Portions21,77518,677

Wood Roasted3,1815,702

Cold Smoked12,58511,588

Other7,5777,158

Total

91,56180,033

UNAUDITEDUNAUDITED

31 July 202331 July 2022

Revenue by Brand$000$000

Ōra King26,55328,403

Regal14,65015,458

Southern Ocean3,6623,364

Omega Plus1,8312,741

New Zealand King Salmon44,86530,067

Total

91,561 80,033

UNAUDITEDUNAUDITED

31 July 202331 July 2022

Revenue by Market$000$000

New Zealand31,131 32,249

North America37,540 30,079

Australia10,987 6,872

Japan2,747 3,109

Europe2,747 3,705

Other6,409 4,019

Total revenue

91,56180,033

15.EVENTS AFTER BALANCE DATE

Dividend

No final dividend was declared in respect of the 6 months ended 31 July 2023 (6 month period to 31 July 2022: Nil).

The following provides the total amount of transactions that were entered into with related parties for the relevant financial year:

The principal activity of The New Zealand King Salmon Co Limited is the farming and processing of salmon. The activity of New Zealand King Salmon

Exports Limited,The New Zealand King Salmon Pty Limited, and New Zealand King Salmon USA Incorporated is the distribution of salmon

Equity Interest

Sales net of settlement discounts to one major customer for the period 1 February 2023 to 31 July 2023 totalled $8.6m, 9.4% of total gross revenue (For

six months to 31 July 2022 one major customer totalled $9.9m or 12.4% of total gross revenue).

During the period NZKS recommenced salmon sales to China through Runkong Food Supply Chain (Guangdong) Co., Ltd., 40% owned by China

Resources Enterprise, Limited, who is a shareholder of NZKS. The sales were conducted on the same terms as an arm’s length transaction.

13

---

1HY24 INVESTOR PRESENTATION
1HY24 FINANCIAL RESULTS

1HY24 INVESTOR PRESENTATION
DISCLAIMER

1

The information in this presentation has been prepared by New Zealand King Salmon Investments Limited with due care and attention. However, to the maximum extent permitted by law, neither

New Zealand King Salmon Investments Limited nor any of its directors, employees, shareholders nor any other person shall haveany liability whatsoever to any person for any loss (including,

without limitation, arising from any fault or negligence) arising from this presentation or any information supplied in connection with it.

This presentation may contain projections or forward-looking statements regarding a variety of items. Such projections or forward-looking statements are based on current expectations, estimates

and assumptions and are subject to a number of risks, uncertainties and assumptions. There is no assurance that results contemplated in any projections and forward-looking statements in this

presentation will be realised and any forward-looking statements are subject to material adverse events, significant one-off expenses or other unforeseeable circumstances. As such, actual results

may differ materially from those projected in this presentation. No person is under any obligation to update this presentation at any time after its release to you or to provide you with further

information about New Zealand King Salmon Investments Limited.

Our results are reported under NZ IFRS. This presentation includes non-GAAP financial measures which are not prepared in accordance with NZ IFRS. The non-GAAP financial measures used in

this presentation include:

•EBITDA. We calculate EBITDA by adding back (or deducting) depreciation, amortisation, finance expense / (income), and taxation expense to net earnings

•EBIT. We calculate EBIT by adding back (or deducting) finance expense / (income), and taxation expense to net earnings

•Pro-Forma Operating EBITDA refers to earnings before interest, tax, depreciation and amortisation after allowing for pro-forma adjustments as described in the Appendix to this document

We believe that these non-GAAP financial measures provide useful information to readers to assist in the understanding of our financial performance, financial position and returns. They should

not, however, be viewed in isolation, nor considered as a substitute for measures reported in accordance with NZ IFRS. Non-GAAP financial measures may not be comparable to similarly titled

amounts reported by other companies.

The information in this presentation is of a general nature and does not constitute financial product advice, investment advice or any recommendation. Nothing in this presentation constitutes legal,

financial, tax or other advice. An investor should, before making any investment decisions, consider the appropriateness of the information in this presentation, and seek professional advice,

having regard to the investor’s objectives, financial situation and needs.

This presentation is solely for use of the party to whom it is provided.

1HY24 INVESTOR PRESENTATION
PRESENTERS

2

Carl Carrington

Chief Executive Officer

Ben Rodgers

Chief Financial Officer

Graeme Tregidga

GM Sales

1HY24 INVESTOR PRESENTATION
EXECUTIVE SUMMARY

3

1HY24

•1HY24 Net profit after tax of $10.6m.The business is performing consistent with expectations following the changes made to the farming model in FY23 (fallowing

3 of 4 Pelorus sites).GAAP results positively impacted by a fair value uplift in assets of $4.1m (1HY23 loss of $8.3m) and continued unwind of early close out of

FX contracts in FY22 $3.6m (1HY23 $3m)

•1HY24 Pro-forma EBITDA profit of $10.7m (1HY23 loss of $12.7

1

m).Rolling 12 month EBITDA $21m

•Mortalityreduction consistent with expectations following changes to the farming model (1HY24 $7.8m v 1HY23 $22.3m).NZKS still see opportunities for further

improvement in this space

•Continuation of focus from FY23 with market choices (price and product optimisation) being successfully implemented in 1HY24,continuous focus on the cost

base and investments in resiliency

•Blue Endeavourmediation complete, consent expected to be issued in 2HY24.

1

1HY23 numbers restated as NZKS is no longer reversing the impacts of NZ IFRS 16 leases as previously communicated

Balance sheet

•Balance Sheet remains strong with net cash on hand $25.2m (up from $15.7m at 31 January2023)

•FY24 Capex is skewed to 2HY24, full year Capex forecast ~$10.5m (1HY24 Capex $1.7m).Projects are focussed on BAU asset replacements to increase

resiliency and reducing risk

Focus Areas

•Optimise and stabilise the existing operations, including investments in resilience to protect core earnings

•Develop production growth options (including Blue Endeavour)

FY24 guidance

update

•Pro-forma EBITDA guidance range revised up to $23.5m to $27.5mfrom previous guidance range of $21m to $25m

•FY24 expected harvest ~6,500 MT

1HY24 INVESTOR PRESENTATION1HY24 INVESTOR PRESENTATION
1HY24 OPERATIONAL HIGHLIGHTS

$92

1HY24

REVENUE OF

MILLION

2,993

METRIC TONNES

HARVESTED

DURING 1HY24

34%

GEOGRAPHIC SPREAD

OF REVENUE

3%

41%

12%

EUROPE

7%

3%

NORTH

AMERICA

ASIA EX JAPAN

JAPAN

NEW

ZEALAND

AUSTRALIA

4

21

-7

-6

-24

11

-30

-20

-10

-

10

20

30

1HY20 (Dec) FY21 (7

months -

Jan)

1HY22 (Jul) 1HY23 (Jul) 1HY24 (Jul)

1HY24 GAAP NPAT

17

11

4

-13

11

-15

-10

-5

0

5

10

15

20

1HY20

(Dec)

FY21 (7

months -

Jan)

1HY22 (Jul) 1HY23 (Jul) 1HY24 (Jul)

1HY23 PRO-FORMA OPERATING EBITDA

1

84

95

80

80

92

1HY20

(Dec)

FY21 (7

months -

Jan)

1HY22

(Jul)

1HY23

(Jul)

1HY24

(Jul)

1

comparable numbers restated as NZKS is no longer reversing the impacts of NZ IFRS 16 leases as

previously communicated

1HY24 INVESTOR PRESENTATION
1HY24 PERFORMANCE

01

5

1HY24 INVESTOR PRESENTATION
KEEPING OUR BRANDS PROMINENT

Creating innovative strategies for our markets:

Connecting with our end-users through:

•Focus on engagement with ŌraKing Ambassadors / key foodservice customers

•Global documentary screenings to tell our story creatively

•Focus to align A&P spend with sales growth and margin targets in each market

•In-house digital and social media programmes for our retail and foodservice brandsto maintain brand

presence with relevant audiences in the most cost-efficient way possible

•Continuously refresh Omega Plus digital, social media and ambassador programmes to increase brand

presence in the NZ and China market

•Focus on activating new specialty strategy for Omega Plus with engaging events and social media

activity with key retailers e.g. Animates

6

Regal Brand Insights

•Regal remains New Zealand’s most preferred smoked salmon brand proving consumer trust in the Regal

brand and theexceptional quality & consistency of our King salmon and value-added product offerings

•Regal Epicurean continues to drive engagement amongst the younger demographic and directly

contributing to our overall positive market share across the Regal range.

1HY24 INVESTOR PRESENTATION
OUR SUSTAINABILITY DEVELOPMENTS

•An industry wide NZ farmed King salmon Life Cycle Assessment was

completed in 2023 showing salmon being a low carbon protein that is high in

Omega-3s and essential nutrients

•Committed to reusable, recyclable or compostable packaging across our

business

•Submission of our third Modern Slavery Report (Australian ModernSlavery

Act 2018)

•Working through the completion of the Best Aquaculture Practices audit for

FY24

•Preparation for the incoming Aotearoa New Zealand Climate Reporting

Standards (effective for current financial year)

•BAP 4-star certification achieved in FY23

We continue to progress on our sustainability journey:

7

Thinkstep-anz. (2023). LCA Report –King Salmon from New Zealand. Wellington: thinkstep-anz

1HY24 INVESTOR PRESENTATION
SALES PERFORMANCE

Continuing to target price and product optimisation

First half salesSecond half sales

NZKSarefocussedonsupplyingourkeymarkets. Costincreasesacrossthebusiness

continuetoprovidechallengesandthiscontinuestobepassedonthroughprice

increases,despitethisglobaldemandremainsstrongandcontinuesto exceedsupply

•NewZealandsalesvolumescontractedandthiswasmostlyinthevalueadded

smokedlines. OurImportedAtlanticvolumescontinuetoincreaseasconsumers

seekvalueoptions.

•NorthAmericanpremiumdemandcontinuestoperformstrongly. Mostofthe

increaseinsalesvolumeis infoodservicewholefishwhichis up25%comparedto

1HY23.OurRegalbrandedretailsmokedproductscontinueto performwell.

•TheJapanmarketvolumesdecreasedwhencomparingtoFY23andisa

continuationofthetrendofthelastfewyearswhichistheresultofthepricing

optimisationmodel.

•Asianmarkets,excludingJapanhada significantliftin1HY24duetoa large

contractforsmokedproduct. Thecorebusinessinthismarketremainsstrongand

hasshowngrowththroughoutthefirsthalfof thisyear.

•TheAustralianmarkethasgrownstronglyduetoa largecontractedvolumeduring

this1HY24.Oursupermarketretailproductscontinuetoperformwellintough

conditionswithrisingcostsbeingpassedonto consumers.

•TheEuropeanmarkethasseensignificantpriceincreasesandthishasbeen

challengingforsomecustomers. Thisis partofourpriceandproductoptimisation

aswefocusonrebuildingourtargetmarkets.

Domestic Market (MT)North America (MT)

Australia (MT)

Europe (MT)

Japan (MT)Asia (MT)Excludes Japan

8

1HY24 INVESTOR PRESENTATION
FISH PERFORMANCE

•The firsthalf of FY24 saw the altered Aquaculture model complete its

first summer. The model of having majorityof stock in the Tory Channel

and away from warmer water sites has proved successful to date with

significantly reduced mortalityin the first half ofFY24 compared to

previous years

•Harvest volume will be up on FY23 but NZKS still see further

optimisation opportunities to increase this again in FY25

•Feed price remains under significant pressuredue toraw material

ingredients, especiallyfish oil which has seen significantincreases in

price

•Monitoring the temperature profile of our sea farm sites is continous,

which includes regular engagement with meteorologists. Work continues

on thermo-tolerance trials with our breeding stock. The aim to be able to

select and breed amore thermo-tolerant salmon. This work is still in its

early phases, however is showing very promising initial results.

9

Biological Performance

1HY241HY23% chg.

Harvest Volume G&G (MT)

2,993

2,7738%

Average G&G Harvest Weight (Kg)3.69

2.88

28%

Closing Livestock Biomass

4,7703,791

26%

Feed Cost ($ / Kg of feed)

3.332.75

21%

SoundFarm

G&G Volume Harvested (MT)

1HY241HY23

Queen Charlotte

Ruakaka

--

Otanerau

229-

Tory Channel

Clay Point

1,567524

Te Pangu

3101,699

Ngamahau

870

-

Pelorus Sound

Waitata

-28

Kōpaua (fallowed)

-124

Waihinau (fallowed)

-

136

Forsyth (fallowed)

-252

Freshwater

17

10

2,9932,773

2018

2019

2020

2021

2022

2023

Mortality Biomass Feb-July last 5 years

1HY24 INVESTOR PRESENTATION
1HY24 RESULTS

02

10

1HY24 INVESTOR PRESENTATION
1HY24 HEADLINE FINANCIAL PERFORMANCE

Volume Sold – increase on the prior period due to the mortality event which reduced

the available biomass for sale in 1HY23

Revenue – increased on the prior period due to the increase in available harvest as

well as improved pricing driven by supportive market dynamics. Revenue and margin

were further enhanced through product optimisation andmarket choices.

Gross Margin % – Increased on the prior period due predominantly to lower

mortalities and reduced cost of fish but also improved pricing and product/market

optimisation. In 1HY24 the GAAP result compared to the pro-forma result was

positively impacted by a fair value gain due to a reduction in forecast mortalities and

improved forecast sales volumes and biomass.

EBITDA – Was positively impacted by the improved Gross Margin noted above as well

as slightly reduced Overheads. The reduction in overheads comes from our continued

focus on efficiency following last years rightsizing of the business. GAAP results

positively impacted by a fair value uplift in assets of $4.1m (1HY23 loss of $8.3m) and

continued unwind of early close out of FX contracts in FY22 ($3.5m)

NPAT– increased on prior period mainly as a result of improved EBITDA but also due

to lower net financing cost following the rights issue in FY23. GAAP NPAT improved

but to a lesser extent (relative to EBITDA) as the tax on the fair value gain weighed on

the result

.

11

1

A full reconciliation between GAAP and Pro-Forma results is shown on pages 19 and 20 of this presentation

2

1HY23 numbers restated as NZKS is no longer reversing the impacts of NZ IFRS 16 leases as previously

communicated

Group Financial Performance

GAAPPro-Forma

1

NZ$000s1HY241HY23% chg.1HY241HY23

2

% chg.

Volume Sold (t)

3,024 2,885 5%3,024 2,885 5%

Revenue

91,561 80,033 14%91,561 80,033 14%

Gross Margin

27,110 (8,045)<>22,939 266 <>

Gross Margin %30%

-10%25%0%

EBITDA18,459 (17,984)<>10,737 (12,696)<>

EBITDA %20%

-22%12%-16%

EBIT14,607 (22,343)<>6,885 (17,055)<>

NPAT

10,630 (24,487)<>4,076(21,526)<>

1HY24 INVESTOR PRESENTATION
PRO-FORMA

1

EBITDA COMPARISON

12

•Revenueas discussed previously is up due to a combination of increased available volume and pricing initiatives

•Cost of goods –was up on prior year driven by volume and cost inflation. NZKS continue to manage inflationary pressures through optimising our Aquaculture and Processing

operations.

•MortalityThe decrease in mortality from 1HY23 reflects the previous summers mortality event which started at the end of FY22 and carriedon into 1HY23. Current mortality

continues to trend near historic lows following the introduction of the new farming model.

•Freight is flat relative to prior year which represents an improvement on a per kg basis from prior year as freight routes open up and providers return to the market having exited

during covid.

1

Refer to pages 19 & 20 for full reconciliation between GAAP and Pro-Forma results

2

1HY23 numbers restated as NZKS is no longer reversing the impacts of NZ IFRS 16 leases as previously communicated

1HY24 INVESTOR PRESENTATION
•NZ King Salmon’s net cash position of $25.2m is an improvement of just under $10m from

January and a vast improvement from a net debt position of $46.7m 18 months ago. This

strong balance sheet gives NZKS a great platform to invest in resilience and the next stage of

growth.

•While strong EBITDA performance provides the backbone of this improved cash position other

areas have also contributed to further strengthen the balance sheet:

►Receivableshave reduced despite increased sales and prices

►Inventoriescontinue to reduce, this time driven by thawing of whole fish frozen down over

last year’s seasonal harvest. This thawed product provides an input into our smoked and

value added products which has allowed us to expand production of these products.

►NZ King Salmon invested a net $1.7m in capexfor the period ended 31 July 2023.

Following a partial pause of all non-essential capex during FY23 we continue to tightly

monitor our Capex spend to ensure that we are maintaining current infrastructure but also

not ignoring shorter term returns while we plan for longer term growth. FY24 capex is

weighted to 2HY24

►The increase in biological assets is a slight drag on cash as we continue to rebuild

biomass following the mortality event in FY22/23 however most of the increase shown is

driven by the non-cash increase in fair value

13

BALANCE SHEET – SOLID PLATFORM FOR GROWTH

Group Financial Position

Jul-23Jan-23

NZ$000sUnauditedAudited

Current Assets

Cash and equivalents28,66619,221

Receivables14,74016,573

Taxation Receivable(998)164

Inventories26,81729,729

Biological Assets70,20660,348

Derivative financial assets1,4231,906

140,854127,941

Non-current Assets

Property, plant & equipment46,94948,176

Biological assets10,30412,344

Other9,86012,827

67,11373,347

Total Assets207,967201,288

Current Liabilities

Loans (external)750750

Lease Liabilities1,0071,191

Payables13,46813,662

Other7,6496,855

22,87422,458

Non-Current Liabilities

Loans (external)2,7502,750

Lease Liabilities3,1093,328

Other5,0024,846

10,86110,924

Total Liabilities33,73533,382

Net Assets174,232167,906

Net Cash / (Debt)25,16615,721

1HY24 INVESTOR PRESENTATION
STRATEGY UPDATE & FY24

UPDATE

15

03

1HY24 INVESTOR PRESENTATION
FY24 GUIDANCE & 12 MONTH ROLLING EBITDA

15

$21m

12 Month Rolling Pro-

Forma EBITDA

$23.5-$27.5m

FY24 Guidance

•Recent farming model changes and the company’s focus on fundamentals is now

reflected in results, as shown by the improvement in the 12-month rolling proforma

EBITDA at $21m

•We have increased our guidance range to $23.5m – $27.5m reflecting strong YTD

performance acknowledging there is inherent uncertainty over the Dec-Jan period.

•Our FY24 guidance is supported by:

oPricing: Current market dynamics continue to create strong pricing support,

particularly in export markets

oFish Performance: Fish performance is ahead of plan from a costing

perspective as our new farming model continues to drive efficiencies

oCost Control: Following the right sizing of the business we are continuing to

push for efficiencies and have created a strong culture around this.

•The performance of the underlying business gives NZKS a strong platform from

which to develop and fund future growth strategies

•Dividends remain on hold as NZKS develops production growth options

1HY24 INVESTOR PRESENTATION
BLUE ENDEAVOUR AND GROWTHSTRATEGY UPDATE

16

•The Consent Order for Blue Endeavour was issued by the Environment court on Sept 19th –This finishes the appeals

process.

•An aquaculture decision by the Ministry of Primary Industries (MPI) is now required to indicate they are satisfied that

the consent will not have an undue adverse effect on fishing (s186C Fisheries Act 1996). This process is expected to

take 2 months.

•The consent has a baseline monitoring period (12 months of monitoring in an 18-month period) before farming can be

undertaken on-site.

•Once monitoring is complete NZKS intends to build a pilot farm on the site to further test the business case for open

ocean farming. NZKS would look to do at least one harvest from this Pilot farm before committing to a progressive

scaling up in order to best manage the risk profile of this investment.

•The 18 month monitoring period affords further time to finalise the key infrastructure requirements that will be needed

to support Blue Endeavour. This is not just the infrastructure needed on the site but may also include:

oFresh water infrastructure to ensure the stability of our supply of smolt to sea at significantly increased volume.

oHarvest and transport infrastructure to make sure we move our salmon in the most efficient and economic

fashion, and maintain fish welfare.

oProcessing infrastructure to efficiently handle the increased throughput

•All these investments will be considered as part of our long-term capital investment program. NZKS will provide

updates to shareholders as these plans are developed.

•The performance of the existing business is a critical element in enabling the growth aspirations.

Consent Granted but

appealed

Mediation begins with

DOC& the McGuiness

Institute

Nov -22

Successful Conclusion

of Mediation

Monitoring

Sep -23

Consent Order Issued

Mar - 23

May - 23

MPI Decision

Nov -23

1HY24 INVESTOR PRESENTATION
17

APPENDICES

04

1HY24 INVESTOR PRESENTATION
EXISTING SEA FARM RESOURCE CONSENTS AND EXPIRY

FarmsRegionExpiry dateStatus

RuakakaQueen Charlotte2024Active

OtanerauQueen Charlotte2024

Active

Forsyth BayPelorus2024Fallow

WaihinauPelorus2024Fallow

Crail Bay x 2Pelorus2024Fallow

Clay PointTory Channel2036

Active

Te PanguTory Channel2036

Active

WaitataPelorus2049

Active

NgamahauTory Channel2049

Active

KopauaPelorus2049Fallow

18

•Five licenses are due for expiry or renewal at the end of 2024, all of which represent warmer, low

flow licenses at lower producing sites

•Crail Bay has not been farmed for around 10 years

•Kōpaua, Forsyth andWaihinauare currently fallowed

•Ruakaka and Otanerau form part of the updated production plan, receiving fish post summer

viatow operations from the Tory Channel farms

•The Marlborough District Council released its decisions on the provisions regulatingmussel

farming in Q2 2023¹.The provisions which relate to salmonfarming were withdrawn.The

Marlborough District Council is working with iwi, the Government and the wider community to

work on new salmonfarming provisions to enablealignment with the NZ Aquaculture

Strategy.NZ King Salmon is involved in thesediscussions.The timing of that process

is uncertain

•Renewingthe 2024 farms will require applications to be lodged.Work on this has

commenced. Should applications be made under the National Environmental Standards for

Marine Aquaculture, there will be limited public notification

•Applications to make the high flow farms operate under a consistent set of consent conditions will

be lodged in the second half of FY24

•Farms will be able to operate on their current consents until all applications and appeals

havebeenresolved

1HY24 INVESTOR PRESENTATION
1HY24 RECONCILIATION BETWEEN GAAP RESULTS AND PRO-FORMA

FINANCIALS

19

1HY24

NZD 000s

Statutory Financial

Statements

Fair Value

Adjustments

Early FX Close-outs

Pro-Forma

Operating Financial

Information

Revenue91,561 91,561

Cost of goods sold(84,435)27,018 (57,417)

Fair value gain / (loss) on biological transformation31,189 (31,189)-

Freight costs to market(11,205)(11,205)

Gross Margin27,110 (4,171)22,940

Other operating income3,974 (3,551)423

Overheads

Sales, marketing and advertising(5,229)(5,229)

Distribution overheads(1,675)(1,675)

Corporate expenses(5,721)(5,721)

Other expenses--

EBITDA18,459 (4,171)(3,551)10,737

Depreciation and amortisation(3,852)(3,852)

EBIT14,607 (4,171)(3,551)6,885

Finance income457 457

Finance costs(183)(183)

Net finance costs274 -274

Profit / (loss) before Tax14,881 (4,171)(3,551)7,159

Income tax (expense) / credit(4,251)1,168 (3,083)

NPAT10,630 (3,003)(3,551)4,076

1HY24 INVESTOR PRESENTATION
1HY23

1

RECONCILIATION BETWEEN GAAP RESULTS AND PRO-FORMA

FINANCIALS

20

1HY23

NZD 000s

Statutory Financial

Statements

Fair Value

Adjustments

Early FX Close-outs

Pro-Forma

Operating Financial

Information

1

Revenue80,033 80,033

Cost of goods sold(89,921)21,533 (68,388)

Fair value gain / (loss) on biological transformation13,222 (13,222)-

Freight costs to market(11,379)(11,379)

Gross Margin(8,045)8,311 266

Other operating income3,312 (3,023)289

Overheads

Sales, marketing and advertising(6,324)(6,324)

Distribution overheads(1,818)(1,818)

Corporate expenses(5,109)(5,109)

Other expenses--

EBITDA(17,984)8,311 (3,023)(12,696)

Depreciation and amortisation(4,359)(4,359)

EBIT(22,343)8,311 (3,023)(17,055)

Finance income116 116

Finance costs(1,276)(1,276)

Net finance costs(1,160)-(1,160)

Profit / (loss) before Tax(23,503)8,311 (3,023)(18,215)

Income tax (expense) / credit(984)(2,327)(3,311)

NPAT(24,487)5,984 (3,023)(21,526)

1

1HY23 numbers restated as NZKS is no longer reversing the impacts of NZ IFRS 16 leases as previously communicated

1HY24 INVESTOR PRESENTATION
APPENDIX – GLOSSARY OF TERMS

1HY24Financial results for the 6 months from 1 February 2023 to 31 July 2023

2HY24Financial results for the 6 months from 1 August 2023 to 31 January 2024

FY24Financial results for the 12 months from 1 February 2023 to 31 January 2024

FY23Financial results for the 12 months from 1 February 2022 to 31 January 2023

EBITDAEarnings before interest, tax, depreciation and amortisation

FCRFeed Conversion Ratio – the amount of feed (in kilograms) required to grow 1 kilogram of fish weight

G&GGilled and gutted. Note that all volumetric information presented is on a gilled and gutted basis unless otherwise stated

GAAPGenerally Accepted Accounting Practice

MTMetric tonnes

NPATNet profit after tax, also reported as net profit for the period in our published financial results

NZKSNew Zealand King Salmon

Pro-Forma Operating EBITDA

Pro-Forma Operating EBITDA refers to earnings before interest, tax, depreciation, amortisation after allowing for pro-forma adjustments as described in the

Appendix to thisdocument. Pro-Forma Operating EBITDA is a non-GAAP profit measure

21

1HY24 INVESTOR PRESENTATION
UNDERSTANDING OUR GAAP RESULTS

The impact of NZ IAS-41 Agriculture and NZ IAS-2 Inventory

Our GAAP results are impacted by Fair Value gains or losses arising from the application of NZ IAS-41 Agriculture and NZ IAS-2 Inventory. The impact

of these standards are explained below:

Fair Value under NZ IAS-41 Agriculture andNZ IAS-2 Inventory

When we record a change in biomass at sea, or where the expected future profit we realise on fish that we sell changes, thesestandards require us to

quantify and recognise the gain or loss in the current period. This applies to both biomass at sea and inventories of finished products.

Our Statement of Financial Position shows biological assets at their fair value. Pro-Forma Operating Financial Performance removes gains / losses associated

with the application of these standards. The company will present Pro-forma results for future reporting periods on this basis.

22

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • NZX — NZX Limited: NZX H1 2023 Results & Interim Report Published
    2023-08-24

    NZX Limited – H1 2023 Results & Interim Report Dear Shareholder, On behalf of the NZX Board, I am pleased to share with you our 2023 Interim Report and Financial Results, which were released today and are available to read online here. We have announced operating earnings (EB…”

  • KFL — Kingfish Limited: KFL – September 2023 monthly update
    2023-09-14

    1 A WORD FROM THE MANAGER In August, Kingfish’s gross performance return was down 3.6% and the adjusted NAV return was also down 3.6%. This compares to the benchmark S&P/NZX50G, which was down 4.2%. New Zealand shares were down during August with only eight companies in the b…”

  • SEK — Seeka Limited: Seeka Announces Result for the Six Months to 30 June 2023
    2023-08-22

    INTERIM RESULTS ANNOUNCEMENT JUNE 2023 | SEEKA LIMITED1 SEEKA SIX MONTHS UNAUDITED INTERIM RESULTS 30 June 2023 Listed New Zealand produce company Seeka, reports its unaudited interim results for the six months ended 30 June 2023. $212.7m Revenue – down 14% on six months to June…”